Celina Whalley
Let’s Go Dotty for Lynch Syndrome – bridging the gap between testing and diagnosis
Supporting Let’s Go Dotty: Lynch Syndrome Awareness Day March 22nd, 2024. A one-test NGS solution for Lynch Syndrome screening.
Read More about Let’s Go Dotty for Lynch Syndrome – bridging the gap between testing and diagnosisScreening for rare disease with next generation sequencing
Screening for rare disease with a clinically enhanced exome panel enabling CNV, SNV and INDEL calling in coding and non-coding regions.
Read More about Screening for rare disease with next generation sequencing4 key factors influencing NGS custom panel design
Factors to take into account when planning custom panel design; target regions, coverage v depth, experimental noise and validation.
Read More about 4 key factors influencing NGS custom panel designFFPE, cfDNA and gDNA: The guide to DNA sample types used in next generation sequencing
Review of DNA types used in next generation sequencing (NGS), their quality characteristics and influence on choice of NGS assay.
Read More about FFPE, cfDNA and gDNA: The guide to DNA sample types used in next generation sequencingTracking the evolution of SARS CoV-2 using whole genome sequencing (WGS)
November 3, 2021. Reviewed by Victoria Simms, April 23, 2024. Why monitoring the evolution of the virus is crucial to public health Viral genome sequencing: the background story Rapid whole viral genome sequencing, decoding a pathogen’s entire genome, is essential to public health organizations and epidemiologists for tracking and surveillance of disease outbreaks. Genomic epidemiologists around the…
Read More about Tracking the evolution of SARS CoV-2 using whole genome sequencing (WGS)